Please enable JavaScript to continue using this application.

Compare $MGX vs $TIL | Chartloom

Compare

$MGX vs $TIL

Metagenomi Therapeutics Inc · Instil Bio Inc

MGX

Metagenomi Therapeutics Inc

TIL

Instil Bio Inc

Compare $MGX vs $TIL

Comparing Metagenomi Therapeutics Inc and Instil Bio Inc

MGXMetagenomi Therapeutics Inc

TILInstil Bio Inc

MGXMetagenomi Therapeutics Inc

Market cap

$38M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.83x

Rev growth (TTM)

-50.7%

YTD performance

-40.1%

52W performance

-68.7%

FCF yield

-227.9%

TILInstil Bio Inc

Market cap

$46M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-40.2%

52W performance

-67.2%

FCF yield

-73.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MGX

TIL

Detailed metrics comparison

MGX

Metagenomi Therapeutics Inc

TIL

Instil Bio Inc

Market Cap

MGX$38M

TIL$46M

Enterprise Value

MGX$-1M

TIL$125M

Price

MGX$1.00

TIL$6.74

P/E Ratio

MGXN/A

TILN/A

P/S Ratio

MGX2.72x

TIL0.00x

EV/Sales

MGX-0.10x

TIL0.00x

EV/EBITDA

MGX0.00x

TIL0.00x

P/B Ratio

MGX0.34x

TIL0.46x

P/FCF Ratio

MGXN/A

TILN/A

EV/FCF

MGX0.02x

TIL-3.73x

PEG Ratio

MGXN/A

TILN/A

Forward P/E (NTM)

MGXN/A

TILN/A

Forward P/S (NTM)

MGX3.83x

TILN/A

Revenue (TTM)

MGX$14M

TIL$0

Revenue Growth (YoY)

MGX-50.7%

TILN/A

Forward Rev Growth

MGX30.0%

TIL0.0%

Gross Margin (TTM)

MGX0.0%

TIL0.0%

Operating Margin (TTM)

MGX0.0%

TIL0.0%

EBITDA Margin (TTM)

MGX-491.3%

TIL0.0%

Net Margin (TTM)

MGX-477.5%

TIL0.0%

FCF Margin (TTM)

MGX-620.9%

TILN/A

Net Income (TTM)

MGX$-66M

TIL$-30M

FCF (TTM)

MGX$-86M

TIL$-34M

EPS (TTM)

MGX$0.00

TIL-$4.46

ROE (TTM)

MGX-5123.0%

TIL-2678.0%

ROA (TTM)

MGX-3662.0%

TIL-1489.0%

ROIC (TTM)

MGX-5123.0%

TIL-1529.0%

Cash

MGX$39M

TIL$6M

Debt

MGX$0

TIL$85M

Net Cash/Debt

MGX$39M

TIL$-80M

Current Ratio (TTM)

MGX4.50x

TIL21.67x

Quick Ratio (TTM)

MGX4.37x

TIL21.19x

Debt/Equity (TTM)

MGX0.00x

TIL0.79x

Debt/Assets (TTM)

MGX0.0%

TIL0.0%

Interest Coverage (TTM)

MGXN/A

TILN/A

Net Debt/EBITDA (TTM)

MGX0.00x

TIL0.00x

Beta

MGX0.68

TIL1.90

52W Performance

MGX-68.7%

TIL-67.2%

YTD Performance

MGX-40.1%

TIL-40.2%

% from 52W High

MGX-74.7%

TIL-69.3%

% from 52W Low

MGX4.2%

TIL18.9%

Asset Turnover (TTM)

MGX0.10x

TIL0.00x

FCF Yield (TTM)

MGX-227.9%

TIL-73.6%

Earnings Yield (TTM)

MGX-175.2%

TIL-66.3%

Dividend Yield (TTM)

MGXN/A

TILN/A

Rule of 40

MGX-671.6

TIL0.0

EV/GP/RG

MGXN/A

TILN/A

Ticker research

View MGX research View TIL research

Metric	MGX Metagenomi Therapeutics Inc	TIL Instil Bio Inc
Market & Valuation
Market Cap	$38M	$46M
Enterprise Value	$-1M	$125M
Price	$1.00	$6.74
P/E Ratio	N/A	N/A
P/S Ratio	2.72x	0.00x
EV/Sales	-0.10x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.34x	0.46x
P/FCF Ratio	N/A	N/A
EV/FCF	0.02x	-3.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.83x	N/A
Revenue & Growth
Revenue (TTM)	$14M	$0
Revenue Growth (YoY)	-50.7%	N/A
Forward Rev Growth	30.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-491.3%	0.0%
Net Margin (TTM)	-477.5%	0.0%
FCF Margin (TTM)	-620.9%	N/A
Net Income (TTM)	$-66M	$-30M
FCF (TTM)	$-86M	$-34M
EPS (TTM)	$0.00	-$4.46
ROE (TTM)	-5123.0%	-2678.0%
ROA (TTM)	-3662.0%	-1489.0%
ROIC (TTM)	-5123.0%	-1529.0%
Financial Health
Cash	$39M	$6M
Debt	$0	$85M
Net Cash/Debt	$39M	$-80M
Current Ratio (TTM)	4.50x	21.67x
Quick Ratio (TTM)	4.37x	21.19x
Debt/Equity (TTM)	0.00x	0.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	1.90
52W Performance	-68.7%	-67.2%
YTD Performance	-40.1%	-40.2%
% from 52W High	-74.7%	-69.3%
% from 52W Low	4.2%	18.9%
Efficiency & Yields
Asset Turnover (TTM)	0.10x	0.00x
FCF Yield (TTM)	-227.9%	-73.6%
Earnings Yield (TTM)	-175.2%	-66.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-671.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MGX research	View TIL research

Valuation

P/S Ratio

TIL

0.00x

MGX

2.72x

EV/FCF

TIL

-3.73x

MGX

0.02x

Growth & revenue

Revenue Growth TTM

MGX

-50.7%

Forward Revenue Growth

MGX

30.0%

TIL

0.0%

Profitability & performance

Gross Margin

MGX

0.0%

TIL

0.0%

ROE

TIL

-2678.0%

MGX

-5123.0%

FCF Yield %

TIL

-73.6%

MGX

-227.9%

52-Week Performance

TIL

-67.2%

MGX

-68.7%

Detailed metrics comparison

MGX

Metagenomi Therapeutics Inc

TIL

Instil Bio Inc

Market Cap

MGX$38M

TIL$46M

Enterprise Value

MGX$-1M

TIL$125M

Price

MGX$1.00

TIL$6.74

P/E Ratio

MGXN/A

TILN/A

P/S Ratio

MGX2.72x

TIL0.00x

EV/Sales

MGX-0.10x

TIL0.00x

EV/EBITDA

MGX0.00x

TIL0.00x

P/B Ratio

MGX0.34x

TIL0.46x

P/FCF Ratio

MGXN/A

TILN/A

EV/FCF

MGX0.02x

TIL-3.73x

PEG Ratio

MGXN/A

TILN/A

Forward P/E (NTM)

MGXN/A

TILN/A

Forward P/S (NTM)

MGX3.83x

TILN/A

Revenue (TTM)

MGX$14M

TIL$0

Revenue Growth (YoY)

MGX-50.7%

TILN/A

Forward Rev Growth

MGX30.0%

TIL0.0%

Gross Margin (TTM)

MGX0.0%

TIL0.0%

Operating Margin (TTM)

MGX0.0%

TIL0.0%

EBITDA Margin (TTM)

MGX-491.3%

TIL0.0%

Net Margin (TTM)

MGX-477.5%

TIL0.0%

FCF Margin (TTM)

MGX-620.9%

TILN/A

Net Income (TTM)

MGX$-66M

TIL$-30M

FCF (TTM)

MGX$-86M

TIL$-34M

EPS (TTM)

MGX$0.00

TIL-$4.46

ROE (TTM)

MGX-5123.0%

TIL-2678.0%

ROA (TTM)

MGX-3662.0%

TIL-1489.0%

ROIC (TTM)

MGX-5123.0%

TIL-1529.0%

Cash

MGX$39M

TIL$6M

Debt

MGX$0

TIL$85M

Net Cash/Debt

MGX$39M

TIL$-80M

Current Ratio (TTM)

MGX4.50x

TIL21.67x

Quick Ratio (TTM)

MGX4.37x

TIL21.19x

Debt/Equity (TTM)

MGX0.00x

TIL0.79x

Debt/Assets (TTM)

MGX0.0%

TIL0.0%

Interest Coverage (TTM)

MGXN/A

TILN/A

Net Debt/EBITDA (TTM)

MGX0.00x

TIL0.00x

Beta

MGX0.68

TIL1.90

52W Performance

MGX-68.7%

TIL-67.2%

YTD Performance

MGX-40.1%

TIL-40.2%

% from 52W High

MGX-74.7%

TIL-69.3%

% from 52W Low

MGX4.2%

TIL18.9%

Asset Turnover (TTM)

MGX0.10x

TIL0.00x

FCF Yield (TTM)

MGX-227.9%

TIL-73.6%

Earnings Yield (TTM)

MGX-175.2%

TIL-66.3%

Dividend Yield (TTM)

MGXN/A

TILN/A

Rule of 40

MGX-671.6

TIL0.0

EV/GP/RG

MGXN/A

TILN/A

Ticker research

View MGX research View TIL research

Metric	MGX Metagenomi Therapeutics Inc	TIL Instil Bio Inc
Market & Valuation
Market Cap	$38M	$46M
Enterprise Value	$-1M	$125M
Price	$1.00	$6.74
P/E Ratio	N/A	N/A
P/S Ratio	2.72x	0.00x
EV/Sales	-0.10x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.34x	0.46x
P/FCF Ratio	N/A	N/A
EV/FCF	0.02x	-3.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.83x	N/A
Revenue & Growth
Revenue (TTM)	$14M	$0
Revenue Growth (YoY)	-50.7%	N/A
Forward Rev Growth	30.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-491.3%	0.0%
Net Margin (TTM)	-477.5%	0.0%
FCF Margin (TTM)	-620.9%	N/A
Net Income (TTM)	$-66M	$-30M
FCF (TTM)	$-86M	$-34M
EPS (TTM)	$0.00	-$4.46
ROE (TTM)	-5123.0%	-2678.0%
ROA (TTM)	-3662.0%	-1489.0%
ROIC (TTM)	-5123.0%	-1529.0%
Financial Health
Cash	$39M	$6M
Debt	$0	$85M
Net Cash/Debt	$39M	$-80M
Current Ratio (TTM)	4.50x	21.67x
Quick Ratio (TTM)	4.37x	21.19x
Debt/Equity (TTM)	0.00x	0.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	1.90
52W Performance	-68.7%	-67.2%
YTD Performance	-40.1%	-40.2%
% from 52W High	-74.7%	-69.3%
% from 52W Low	4.2%	18.9%
Efficiency & Yields
Asset Turnover (TTM)	0.10x	0.00x
FCF Yield (TTM)	-227.9%	-73.6%
Earnings Yield (TTM)	-175.2%	-66.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-671.6	0.0
EV/GP/RG	N/A	N/A
Ticker research	View MGX research	View TIL research